AAAAAA

   
Results: 1-7 |
Results: 7
IMMUNOCYTOCHEMICAL DETECTION OF SOMATOSTATIN RECEPTORS SST(1), SST(2A), SST(2B), AND SST(3) IN PARAFFIN-EMBEDDED BREAST-CANCER TISSUE USINGSUBTYPE-SPECIFIC ANTIBODIES
Authors: SCHULZ S SCHULZ S SCHMITT J WIBORNY D SCHMIDT H OLBRICHT S WEISE W ROESSNER A GRAMSCH C HOLLT V
Citation: S. Schulz et al., IMMUNOCYTOCHEMICAL DETECTION OF SOMATOSTATIN RECEPTORS SST(1), SST(2A), SST(2B), AND SST(3) IN PARAFFIN-EMBEDDED BREAST-CANCER TISSUE USINGSUBTYPE-SPECIFIC ANTIBODIES, Clinical cancer research, 4(9), 1998, pp. 2047-2052
NODULAR HIDRADENOMA - A REPORT OF 3 CASES AND REVIEW OF THE LITERATURE
Authors: STRATIGOS AJ OLBRICHT S KWAN TH BOWERS KE
Citation: Aj. Stratigos et al., NODULAR HIDRADENOMA - A REPORT OF 3 CASES AND REVIEW OF THE LITERATURE, Dermatologic surgery, 24(3), 1998, pp. 387-391
CISPLATIN PACLITAXEL VS CARBOPLATIN/PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN OVARIAN-CANCER - AN AGO STUDY-GROUP PHASE-III TRIAL/
Authors: MOBUS V SCHODER W LUCK HJ MEIER W RICHTER B WARM M COSTA S BAUKNECHT T OLBRICHT S NITZ U JACKISCH C DUBOIS A
Citation: V. Mobus et al., CISPLATIN PACLITAXEL VS CARBOPLATIN/PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN OVARIAN-CANCER - AN AGO STUDY-GROUP PHASE-III TRIAL/, Annals of oncology, 9, 1998, pp. 661-661
CARBOPLATIN PACLITAXEL VERSUS CISPLATIN/PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - AN INTERIM ANALYSIS OF A RANDOMIZED PHASE-III TRIAL OF THE ARBEITSGEMEINSCHAFT GYNAKOLOGISCHE-ONKOLOGIE OVARIAN-CANCER STUDY-GROUP/
Authors: DUBOIS A LUCK HJ MEIER W MOBUS V COSTA S RICHTER B WARM M BAUKNECHT T SCHRODER W OLBRICHT S NITZ U JACKISCH C
Citation: A. Dubois et al., CARBOPLATIN PACLITAXEL VERSUS CISPLATIN/PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - AN INTERIM ANALYSIS OF A RANDOMIZED PHASE-III TRIAL OF THE ARBEITSGEMEINSCHAFT GYNAKOLOGISCHE-ONKOLOGIE OVARIAN-CANCER STUDY-GROUP/, Seminars in oncology, 24(5), 1997, pp. 44-52
CARBOPLATIN PLUS PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN PREVIOUSLY UNTREATED ADVANCED OVARIAN-CANCER
Authors: DUBOIS A LUCK HJ MEIER W MOBUS V COSTA S RICHTER B BAUKNECHT T WARM M SCHROEDER W OLBRICHT S NITZ U JACKISCH C
Citation: A. Dubois et al., CARBOPLATIN PLUS PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN PREVIOUSLY UNTREATED ADVANCED OVARIAN-CANCER, Seminars in oncology, 24(4), 1997, pp. 28-33
THE SAME DOMINANT T-CELL CLONE IS PRESENT IN MULTIPLE REGRESSING SKIN-LESIONS AND ASSOCIATED T-CELL LYMPHOMAS OF PATIENTS WITH LYMPHOMATOIDPAPULOSIS
Authors: CHOTT A VONDERHEID EC OLBRICHT S MIAO NN BALK SP KADIN ME
Citation: A. Chott et al., THE SAME DOMINANT T-CELL CLONE IS PRESENT IN MULTIPLE REGRESSING SKIN-LESIONS AND ASSOCIATED T-CELL LYMPHOMAS OF PATIENTS WITH LYMPHOMATOIDPAPULOSIS, Journal of investigative dermatology, 106(4), 1996, pp. 696-700
GUIDELINES OF CARE FOR LOCAL AND REGIONAL ANESTHESIA IN CUTANEOUS SURGERY
Authors: DRAKE LA DINEHART SM GOLTZ RW GRAHAM GF HORDINSKY MK LEWIS CW PARISER DM SKOUGE JW TURNER MLC WEBSTER SB WHITAKER DC BUTLER B LOWERY BJ BRIDENSTINE JB OLBRICHT S WINTON GB
Citation: La. Drake et al., GUIDELINES OF CARE FOR LOCAL AND REGIONAL ANESTHESIA IN CUTANEOUS SURGERY, Journal of the American Academy of Dermatology, 33(3), 1995, pp. 504-509
Risultati: 1-7 |